Table 3. Myeloid Differentiation Marker... | American Society of Hematology

Table 3.

Myeloid Differentiation Marker Expression in Oligomer- and PMA-Treated HL60 Cells

Marker	Untreated	AS-Treated	S-Treated	IP-Treated
α-Naphthylbutyrate esterase^3-150	65	7	67	69
Naphthol-AS-D-cloroacetate esterase^3-150	10	7	6	6
Myeloperoxydase^3-150	10	97	8	14
CD11c^†	90.7	12.4	91.7	94.3
CD14^†	2.1	4.3	2.7	5.2
CD45^†	95.7	94.8	97.3	90.9

Marker	Untreated	AS-Treated	S-Treated	IP-Treated
α-Naphthylbutyrate esterase^3-150	65	7	67	69
Naphthol-AS-D-cloroacetate esterase^3-150	10	7	6	6
Myeloperoxydase^3-150	10	97	8	14
CD11c^†	90.7	12.4	91.7	94.3
CD14^†	2.1	4.3	2.7	5.2
CD45^†	95.7	94.8	97.3	90.9

Values represent the average of three separate experiments. The variability was less than 10%.

Percent of positive cells determined by cytochemistry, and † by flow cytometry.